US 8795964
GRM3 mutations and use thereof for the diagnosis and treatment of melanoma
granted A61KA61K31/4184
Quick answer
US patent 8795964 (GRM3 mutations and use thereof for the diagnosis and treatment of melanoma) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jul 31 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Aug 05 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 31 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/4184